World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
46077
World Ranking
12915
National Ranking
6601

Stuart Rich publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stuart Rich sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 260 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stuart Rich D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stuart Rich sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stuart Rich is affiliated with Northwestern University in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Cardiology and Cardiovascular Medicine as well as Pulmonary and Respiratory Medicine. Their work also touches on Complementary and alternative medicine, Epidemiology, and Biomedical Engineering.

The main topics covered by their research include:

  • Pulmonary Hypertension Research and Treatments
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Issues in Pregnancy
  • Cardiovascular and Exercise Physiology
  • Congenital Heart Disease Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research

Recent publications by Stuart Rich feature studies in prominent journals:

  • Venous Tone and Stressed Blood Volume in Heart Failure, 2022, Journal of the American College of Cardiology
  • Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF, 2021, JACC Heart Failure
  • Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021, 2024, The Lancet Respiratory Medicine
  • Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study, 2021, Pulmonary Circulation
  • Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop, 2021, Circulation Heart Failure

Frequent co-authors collaborating with Stuart Rich include:

  • Daniel Burkhoff
  • Barry A. Borlaug
  • Sanjiv J. Shah
  • Ryan J. Tedford
  • Navin K. Kapur

The scientist's work has been published repeatedly in several key venues, with multiple contributions across these journals:

  • Journal of Cardiac Failure
  • Pulmonary Circulation
  • Journal of the American College of Cardiology
  • Circulation Heart Failure
  • Circulation

Best Publications

  • Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry

    Gilbert E. D'Alonzo;Robyn J. Barst;Stephen M. Ayres;Edward H. Bergofsky

  • A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Robyn J. Barst;Lewis J. Rubin;Walker A. Long;Michael D. McGoon

  • PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY

    S Rich;D R Dantzker;S M Ayres;E H Bergofsky

  • Clinical classification of pulmonary hypertension

    Gerald Simonneau;Nazzareno Galiè;Lewis J Rubin;David Langleben

  • The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

    Stuart Rich;Elizabeth Kaufmann;Paul S. Levy

  • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

    Gerald Simonneau;Robyn J. Barst;Nazzareno Galie;Robert Naeije

  • Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

    Lucien Abenhaim;Yola Moride;François Brenot;Stuart Rich

  • Survival in Primary Pulmonary Hypertension The Impact of Epoprostenol Therapy

    Vallerie V. McLaughlin;Alicia Shillington;Stuart Rich

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Appetite-suppressant drugs and the risk of primary pulmonary hypertension

    L. Abenhaim;Yola Moride;F. Brenot;S. Rich

  • Beraprost therapy for pulmonary arterial hypertension

    Robyn J. Barst;Michael McGoon;Vallerie McLaughlin;Victor Tapson

  • Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension

    Vallerie V. McLaughlin;Diane E. Genthner;Maureen M. Panella;Stuart Rich

  • Ultrafast Computed Tomography as a Diagnostic Modality in the Detection of Coronary Artery Disease A Multicenter Study

    Matthew J. Budoff;Demetrios Georgiou;Alan Brody;Arthur S. Agatston

  • Pulmonary arterial hypertension: epidemiology and registries

    Michael D. McGoon;Raymond L. Benza;Pilar Escribano-Subias;Xin Jiang

  • Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.

    G G Pietra;W D Edwards;J M Kay;S Rich

  • A USA-based registry for pulmonary arterial hypertension: 1982–2006

    Thenappan Thenappan;S. J. Shah;S. Rich;M. Gomberg-Maitland

  • Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults.

    Julie Anne Hoff;Eva V. Chomka;Andrew J. Krainik;Martha Daviglus

  • Primary Pulmonary Hypertension A Vascular Biology and Translational Research “Work in Progress”

    Stephen Archer;Stuart Rich

  • Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation

    Thenappan Thenappan;S. J. Shah;S. Rich;L. Tian

  • Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension

    V. V. McLauehlin;D. E. Genthner;M. M. Panella;S. Rich

Frequent Co-Authors

Stephen L. Archer
Stephen L. Archer Queen's University
Sanjiv J. Shah
Sanjiv J. Shah Northwestern University
Lewis J. Rubin
Lewis J. Rubin University of California, San Diego
David B. Badesch
David B. Badesch University of Colorado Denver
Victor F. Tapson
Victor F. Tapson Duke University
Robyn J. Barst
Robyn J. Barst Columbia University
Robert C. Bourge
Robert C. Bourge University of Alabama at Birmingham
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Alfred P. Fishman
Alfred P. Fishman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying Medicine in the USA, there are many related online degrees and career pathways to explore. Specialized programs like psych np programs are an excellent option for those who want to focus on mental health nursing. These advanced nursing degrees offer flexible online formats and can accelerate your path to becoming a specialist nurse practitioner.

For those interested in the business side of healthcare, online healthcare administration programs and affordable mha online degrees provide a pathway into leadership and management roles. These programs can lead to careers in hospital administration, healthcare consulting, and policy analysis.

Advancing your medical career can also involve pursuing terminal degrees, such as a Doctor of Nursing Practice. If cost is a concern, check out the cheapest dnp program options available online to find high-quality education at an affordable price. These various degrees greatly broaden your career trajectory in the healthcare field.

Best Scientists Citing Stuart Rich

Trending Scientists

Recently Published Articles